Bosh sahifa45E • FRA
add
Natera Inc
Yopilish kursi
174,30 €
Kunlik diapazon
165,35 € - 165,35 €
Yillik diapazon
158,00 € - 216,00 €
Bozor kapitalizatsiyasi
29,54 mlrd USD
Oʻrtacha hajm
1,00
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 665,50 mln | 39,79% |
Joriy xarajat | 468,21 mln | 28,50% |
Sof foyda | 47,26 mln | 187,89% |
Sof foyda marjasi | 7,10 | 162,89% |
Har bir ulushga tushum | 0,36 | 187,80% |
EBITDA | -13,69 mln | 77,35% |
Amaldagi soliq stavkasi | 454,63% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,08 mlrd | 11,14% |
Jami aktivlari | 2,40 mlrd | 44,41% |
Jami passivlari | 685,93 mln | 47,41% |
Umumiy kapital | 1,71 mlrd | — |
Tarqatilgan aksiyalar | 141,73 mln | — |
Narxi/balansdagi bahosi | 14,22 | — |
Aktivlardan daromad | -2,70% | — |
Kapitaldan daromad | -3,37% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 47,26 mln | 187,89% |
Operatsiyalardan naqd pul | 73,89 mln | 39,71% |
Sarmoyadan naqd pul | -71,59 mln | -543,93% |
Moliyadan naqd pul | 32,41 mln | 195,30% |
Naqd pulning sof oʻzgarishi | 34,70 mln | -34,21% |
Boʻsh pul | 16,99 mln | -69,31% |
Haqida
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Tashkil etilgan
1-yan, 2004
Sayt
Xodimlar soni
6 138
